90 related articles for article (PubMed ID: 36529792)
1. Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity.
Li CX; Wang JS; Wang WN; Xu DK; Zhou YT; Sun FZ; Li YQ; Guo FZ; Ma JL; Zhang XY; Chang MJ; Xu BH; Ma F; Qian HL
Mil Med Res; 2022 Dec; 9(1):71. PubMed ID: 36529792
[TBL] [Abstract][Full Text] [Related]
2. The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response.
Shkreta L; Toutant J; Delannoy A; Durantel D; Salvetti A; Ehresmann S; Sauvageau M; Delbrouck JA; Gravel-Trudeau A; Comeau C; Huard C; Coulombe-Huntington J; Tyers M; Grierson D; Boudreault PL; Chabot B
Oncotarget; 2024 May; 15():313-325. PubMed ID: 38753413
[TBL] [Abstract][Full Text] [Related]
3. Gene expression and alternative splicing contribute to adaptive divergence of ecotypes.
Innes PA; Goebl AM; Smith CCR; Rosenberger K; Kane NC
Heredity (Edinb); 2024 Mar; 132(3):120-132. PubMed ID: 38071268
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection severity and mortality is modulated by repeat-mediated regulation of alternative splicing.
Mehta P; Chattopadhyay P; Ravi V; Tarai B; Budhiraja S; Pandey R
Microbiol Spectr; 2023 Aug; 11(5):e0135123. PubMed ID: 37604131
[TBL] [Abstract][Full Text] [Related]
5. Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer.
Namba S; Ueno T; Kojima S; Kobayashi K; Kawase K; Tanaka Y; Inoue S; Kishigami F; Kawashima S; Maeda N; Ogawa T; Hazama S; Togashi Y; Ando M; Shiraishi Y; Mano H; Kawazu M
Commun Biol; 2021 Nov; 4(1):1320. PubMed ID: 34811492
[TBL] [Abstract][Full Text] [Related]
6. Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects.
Gross SM; Mohammadi F; Sanchez-Aguila C; Zhan PJ; Liby TA; Dane MA; Meyer AS; Heiser LM
Nat Commun; 2023 Jun; 14(1):3450. PubMed ID: 37301933
[TBL] [Abstract][Full Text] [Related]
7. CanISO: a database of genomic and transcriptomic variations in domestic dog (Canis lupus familiaris).
Yang IS; Jang I; Yang JO; Choi J; Kim MS; Kim KK; Seung BJ; Cheong JH; Sur JH; Nam H; Lee B; Kim J; Kim S
BMC Genomics; 2023 Oct; 24(1):613. PubMed ID: 37828501
[TBL] [Abstract][Full Text] [Related]
8. Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation.
Ford K; Munson BP; Fong SH; Panwala R; Chu WK; Rainaldi J; Plongthongkum N; Arunachalam V; Kostrowicki J; Meluzzi D; Kreisberg JF; Jensen-Pergakes K; VanArsdale T; Paul T; Tamayo P; Zhang K; Bienkowska J; Mali P; Ideker T
Sci Rep; 2023 May; 13(1):7678. PubMed ID: 37169829
[TBL] [Abstract][Full Text] [Related]
9. BRIE2: computational identification of splicing phenotypes from single-cell transcriptomic experiments.
Huang Y; Sanguinetti G
Genome Biol; 2021 Aug; 22(1):251. PubMed ID: 34452629
[TBL] [Abstract][Full Text] [Related]
10. Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies.
Karakulak T; Moch H; von Mering C; Kahraman A
Front Mol Biosci; 2021; 8():726902. PubMed ID: 34888349
[TBL] [Abstract][Full Text] [Related]
11. Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects.
Sinkala M; Naran K; Ramamurthy D; Mungra N; Dzobo K; Martin D; Barth S
PLoS One; 2024; 19(2):e0296511. PubMed ID: 38306344
[TBL] [Abstract][Full Text] [Related]
12. Alternative promoters and splicing create multiple functionally distinct isoforms of oestrogen receptor alpha in breast cancer and healthy tissues.
Balcazar Lopez CE; Albrecht J; Hafstað V; Börjesson Freitag C; Vallon-Christersson J; Bellodi C; Persson H
Cancer Med; 2023 Sep; 12(18):18931-18945. PubMed ID: 37676103
[TBL] [Abstract][Full Text] [Related]
13. A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response.
Koukouli E; Wang D; Dondelinger F; Park J
PLoS Comput Biol; 2021 Jan; 17(1):e1008066. PubMed ID: 33493149
[TBL] [Abstract][Full Text] [Related]
14. Splicing inhibition mediated by reduced splicing factors and helicases is associated with the cellular response of lung cancer cells to cisplatin.
Wang L; Yin N; Shi W; Xie Y; Yi J; Tang Z; Tang J; Xiang J
Comput Struct Biotechnol J; 2024 Dec; 23():648-658. PubMed ID: 38283853
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer.
Geng DY; Chen QS; Chen WX; Zhou LS; Han XS; Xie QH; Guo GH; Chen XF; Chen JS; Zhong XP
World J Clin Oncol; 2024 Apr; 15(4):531-539. PubMed ID: 38689626
[TBL] [Abstract][Full Text] [Related]
16. Revisiting inconsistency in large pharmacogenomic studies.
Safikhani Z; Smirnov P; Freeman M; El-Hachem N; She A; Rene Q; Goldenberg A; Birkbak NJ; Hatzis C; Shi L; Beck AH; Aerts HJWL; Quackenbush J; Haibe-Kains B
F1000Res; 2016; 5():2333. PubMed ID: 28928933
[TBL] [Abstract][Full Text] [Related]
17.
Shi X; Facemire L; Singh S; Kumar S; Cornelison R; Liang C; Qin F; Liu A; Lin S; Tang Y; Elfman J; Manley T; Bullock T; Haverstick DM; Wu P; Li H
bioRxiv; 2024 Feb; ():. PubMed ID: 38405903
[TBL] [Abstract][Full Text] [Related]
18. Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics.
Mehmood A; Nawab S; Jin Y; Hassan H; Kaushik AC; Wei DQ
ACS Pharmacol Transl Sci; 2023 Mar; 6(3):399-409. PubMed ID: 36926455
[TBL] [Abstract][Full Text] [Related]
19. Assessment of pharmacogenomic agreement.
Safikhani Z; El-Hachem N; Quevedo R; Smirnov P; Goldenberg A; Juul Birkbak N; Mason C; Hatzis C; Shi L; Aerts HJ; Quackenbush J; Haibe-Kains B
F1000Res; 2016; 5():825. PubMed ID: 27408686
[TBL] [Abstract][Full Text] [Related]
20. Predicting drug response through tumor deconvolution by cancer cell lines.
Hsu YC; Chiu YC; Lu TP; Hsiao TH; Chen Y
Patterns (N Y); 2024 Apr; 5(4):100949. PubMed ID: 38645769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
